146 related articles for article (PubMed ID: 28504462)
1. Endocytic activity of HIV-1 Vpu: Phosphoserine-dependent interactions with clathrin adaptors.
Stoneham CA; Singh R; Jia X; Xiong Y; Guatelli J
Traffic; 2017 Aug; 18(8):545-561. PubMed ID: 28504462
[TBL] [Abstract][Full Text] [Related]
2. Serine Phosphorylation of HIV-1 Vpu and Its Binding to Tetherin Regulates Interaction with Clathrin Adaptors.
Kueck T; Foster TL; Weinelt J; Sumner JC; Pickering S; Neil SJ
PLoS Pathog; 2015 Aug; 11(8):e1005141. PubMed ID: 26317613
[TBL] [Abstract][Full Text] [Related]
3. Phosphoserine acidic cluster motifs bind distinct basic regions on the μ subunits of clathrin adaptor protein complexes.
Singh R; Stoneham C; Lim C; Jia X; Guenaga J; Wyatt R; Wertheim JO; Xiong Y; Guatelli J
J Biol Chem; 2018 Oct; 293(40):15678-15690. PubMed ID: 30135209
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 Vpu Antagonizes CD317/Tetherin by Adaptor Protein-1-Mediated Exclusion from Virus Assembly Sites.
Pujol FM; Laketa V; Schmidt F; Mukenhirn M; Müller B; Boulant S; Grimm D; Keppler OT; Fackler OT
J Virol; 2016 Aug; 90(15):6709-6723. PubMed ID: 27170757
[TBL] [Abstract][Full Text] [Related]
5. Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking.
Mitchell RS; Katsura C; Skasko MA; Fitzpatrick K; Lau D; Ruiz A; Stephens EB; Margottin-Goguet F; Benarous R; Guatelli JC
PLoS Pathog; 2009 May; 5(5):e1000450. PubMed ID: 19478868
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 Vpu inhibits accumulation of the envelope glycoprotein within clathrin-coated, Gag-containing endosomes.
Van Damme N; Guatelli J
Cell Microbiol; 2008 May; 10(5):1040-57. PubMed ID: 18076669
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of HIV-1 Vpu-mediated BST2 antagonism via hijacking of the clathrin adaptor protein complex 1.
Jia X; Weber E; Tokarev A; Lewinski M; Rizk M; Suarez M; Guatelli J; Xiong Y
Elife; 2014 Apr; 3():e02362. PubMed ID: 24843023
[TBL] [Abstract][Full Text] [Related]
8. Conserved residues within the HIV-1 Vpu transmembrane-proximal hinge region modulate BST2 binding and antagonism.
Lukhele S; Cohen ÉA
Retrovirology; 2017 Mar; 14(1):18. PubMed ID: 28288652
[TBL] [Abstract][Full Text] [Related]
9. A combined EM and proteomic analysis places HIV-1 Vpu at the crossroads of retromer and ESCRT complexes: PTPN23 is a Vpu-cofactor.
Stoneham CA; Langer S; De Jesus PD; Wozniak JM; Lapek J; Deerinck T; Thor A; Pache L; Chanda SK; Gonzalez DJ; Ellisman M; Guatelli J
PLoS Pathog; 2021 Nov; 17(11):e1009409. PubMed ID: 34843601
[TBL] [Abstract][Full Text] [Related]
10. Interferon-induced SCYL2 limits release of HIV-1 by triggering PP2A-mediated dephosphorylation of the viral protein Vpu.
Miyakawa K; Sawasaki T; Matsunaga S; Tokarev A; Quinn G; Kimura H; Nomaguchi M; Adachi A; Yamamoto N; Guatelli J; Ryo A
Sci Signal; 2012 Oct; 5(245):ra73. PubMed ID: 23047923
[TBL] [Abstract][Full Text] [Related]
11. A novel peptide to disrupt the interaction of BST-2 and Vpu.
Mi Z; Wang X; He Y; Li X; Ding J; Liu H; Zhou J; Cen S
Biopolymers; 2014 May; 102(3):280-7. PubMed ID: 24676648
[TBL] [Abstract][Full Text] [Related]
12. The human immunodeficiency virus type 1 Vpu protein tethered to the CD4 extracellular domain is localized to the plasma membrane and is biologically active in the secretory pathway of mammalian cells: implications for the mechanisms of Vpu function.
Raja NU; Jabbar MA
Virology; 1996 Jun; 220(1):141-51. PubMed ID: 8659106
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of both phosphoacceptor sites in the HIV-1 Vpu cytoplasmic domain is essential for Vpu-mediated ER degradation of CD4.
Paul M; Jabbar MA
Virology; 1997 May; 232(1):207-16. PubMed ID: 9185604
[TBL] [Abstract][Full Text] [Related]
14. Structural consequences of phosphorylation of two serine residues in the cytoplasmic domain of HIV-1 VpU.
Wittlich M; Koenig BW; Willbold D
J Pept Sci; 2008 Jul; 14(7):804-10. PubMed ID: 18186541
[TBL] [Abstract][Full Text] [Related]
15. Regulated degradation of the HIV-1 Vpu protein through a betaTrCP-independent pathway limits the release of viral particles.
Estrabaud E; Le Rouzic E; Lopez-Vergès S; Morel M; Belaïdouni N; Benarous R; Transy C; Berlioz-Torrent C; Margottin-Goguet F
PLoS Pathog; 2007 Jul; 3(7):e104. PubMed ID: 17676996
[TBL] [Abstract][Full Text] [Related]
16. Epitope mapping of the phosphorylation motif of the HIV-1 protein Vpu bound to the selective monoclonal antibody using TRNOESY and STD NMR spectroscopy.
Gharbi-Benarous J; Bertho G; Evrard-Todeschi N; Coadou G; Megy S; Delaunay T; Benarous R; Girault JP
Biochemistry; 2004 Nov; 43(46):14555-65. PubMed ID: 15544326
[TBL] [Abstract][Full Text] [Related]
17. NMR studies of the phosphorylation motif of the HIV-1 protein Vpu bound to the F-box protein beta-TrCP.
Coadou G; Gharbi-Benarous J; Megy S; Bertho G; Evrard-Todeschi N; Segeral E; Benarous R; Girault JP
Biochemistry; 2003 Dec; 42(50):14741-51. PubMed ID: 14674748
[TBL] [Abstract][Full Text] [Related]
18. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif.
Margottin F; Bour SP; Durand H; Selig L; Benichou S; Richard V; Thomas D; Strebel K; Benarous R
Mol Cell; 1998 Mar; 1(4):565-74. PubMed ID: 9660940
[TBL] [Abstract][Full Text] [Related]
19. The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation.
Bour S; Schubert U; Strebel K
J Virol; 1995 Mar; 69(3):1510-20. PubMed ID: 7853484
[TBL] [Abstract][Full Text] [Related]
20. Multilayered mechanism of CD4 downregulation by HIV-1 Vpu involving distinct ER retention and ERAD targeting steps.
Magadán JG; Pérez-Victoria FJ; Sougrat R; Ye Y; Strebel K; Bonifacino JS
PLoS Pathog; 2010 Apr; 6(4):e1000869. PubMed ID: 20442859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
